Antonio Silvani1. Show Affiliations » 1. Istituto Nazionale Neurologico Carlo Besta, Milano.
Abstract
Entities: Chemical
Mesh： See more » AdultAntimetabolites, Antineoplastic/administration & dosageAntimetabolites, Antineoplastic/adverse effectsAntimetabolites, Antineoplastic/therapeutic useAstrocytoma/complicationsAstrocytoma/drug therapyBrain Neoplasms/pathologyBreast Neoplasms/pathologyCarcinoma/complicationsCarcinoma/drug therapyCarcinoma, Non-Small-Cell Lung/complicationsCarcinoma, Non-Small-Cell Lung/drug therapyCerebellar Neoplasms/pathologyCytarabine/administration & dosageCytarabine/therapeutic useDrug EvaluationFemaleHeadache/chemically inducedHumansInjections, SpinalLiposomesLung Neoplasms/pathologyMaleMedulloblastoma/complicationsMedulloblastoma/drug therapyMeningitis/drug therapyMeningitis/etiologyNeuroectodermal Tumors, Primitive/complicationsNeuroectodermal Tumors, Primitive/drug therapyPalliative CareProspective StudiesRetrospective StudiesTreatment Outcome
Substances： See more » Antimetabolites, AntineoplasticLiposomesCytarabine
Year: 2007 PMID： 17679480
Source DB: PubMed Journal: Tumori ISSN： 0300-8916 Impact factor: 2.098